Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-19

Clinical Trial Update: Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety and efficacy of applying bimatoprost to the eyelid margin to treat hypotrichosis of the eyelashes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Hypotrichosis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-19